Has-miR-11181-3p and its predicted target gene(TGFΒR1) expression levels were measured in 14 normal brain and braintumour tissues, including meningioma, glioma, schwannoma, and adenoma samples (Fig .3) andAD. This evidence concerns the gene TGFBR1 and central nervous system cancer.